NCT06721871View on ClinicalTrials.gov

Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

March 31, 2026

Conditions
Microvillus Inclusion DiseaseCongenital DisordersRare Diseases
Interventions
DRUG

Crofelemer Powder for Oral Solution

Crofelemer Powder for Oral Solution

DRUG

Placebo Powder for Oral Solution

Matching Placebo Powder for Oral Solution

Trial Locations (3)

02115

RECRUITING

Boston Children's Hospital, Boston

Unknown

NOT_YET_RECRUITING

UOS Gastroenterolgia e Riabilitazione nutrizionale Piazza Sant' Onofrio 4, Rome

RECRUITING

Al Jalila Children's Hospital, Dubai

Sponsors
All Listed Sponsors
lead

Napo Pharmaceuticals, Inc.

INDUSTRY

NCT06721871 - Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) | Biotech Hunter | Biotech Hunter